LT - 6-Okso-1,6-dihidro-piridazino darinys, skirtas naudoti hepatoceliulinės karcinomos (HCC) gydymui
EN - A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR THE USE FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC)
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/506 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2914264 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13776720.8 |
|
Date of filing the European patent application |
2013-10-04 |
| (97) |
Date of publication of the European application |
2015-09-09 |
| (45) |
Date of publication and mention of the grant of the patent |
2017-08-09
|
| (46) |
Date of publication of the claims translation |
2017-11-10
|
PCT application
| (86) |
Number |
PCT/EP2013/002998 |
|
Date |
2013-10-04 |
PCT application publication
| (87) |
Number |
WO 2014/067610 |
|
Date |
2014-05-08 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
12007494 |
2012-11-02
|
EP |
Inventors
| (72) |
FRIESE-HAMIM, Manja, DE
BLADT, Friedhelm, DE
|
Grantee
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
6-Okso-1,6-dihidro-piridazino darinys, skirtas naudoti hepatoceliulinės karcinomos (HCC) gydymui |
| |
A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR THE USE FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-09-18 |
11 |
289.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-10-04 |
